Effect of Cabergoline on rheumatiod Arthritis patient.

Trial Profile

Effect of Cabergoline on rheumatiod Arthritis patient.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Cabergoline (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2011 New trial record
    • 21 Apr 2010 Recruitment complete, according to the Iranian Registry of Clinical Trials
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top